RecruitingNCT06284343

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Development and Validation of a Risk Prediction Model for Venous Thromboembolism in Gynecological Cancer Patients Undergoing Systemic Antineoplastic Treatment: The Gynecological Cancer Associated Thrombosis (GynCAT) Study


Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

1,800 participants

Start Date

Apr 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking blood clot (thrombosis) risk in women with gynecologic cancers (ovarian, uterine, cervical, vaginal, or vulvar) who are starting a new round of cancer treatment, to better understand and predict clotting events. **You may be eligible if...** - You are female and have been diagnosed with a gynecologic cancer (ovarian, fallopian tube, uterine, cervical, vaginal, or vulvar) - You are starting a new line of cancer treatment - You are 18 years or older **You may NOT be eligible if...** - You are pregnant or breastfeeding - You already need blood thinners at a full therapeutic dose (e.g., for atrial fibrillation or a mechanical heart valve) - You have already been diagnosed with a symptomatic blood clot at the time of enrollment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAnticoagulant

Prescription of pharmacological thromboprophylaxis according to current clinical practice and international guidelines recommendation


Locations(1)

Agostino Gemelli University Polyclinic Foundation IRCCS

Rome, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06284343


Related Trials